More Alzheimer ' s Drug Trial Failures: Are Researchers on the Wrong Track?

WEDNESDAY, April 10, 2019 -- Amyloid beta has long been a prime suspect in Alzheimer ' s disease, since abnormal levels of the protein form disruptive plaques between patients ' brain cells. But drug trials aimed at lowering amyloid levels have...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news